
Keywords: سرطان ریه سلول های غیر سلولی پیشرفته; AE; adverse event; ALK; anaplastic lymphoma kinase; aNSCLC; advanced non-small cell lung cancer; DRG; diagnosis-related group; EGFR; epidermal growth factor receptor; GLM; generalized linear model; HMO; health maintenance organization; HR; hazard ratio; I